← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2008Last known activity
Nov 14, 2018
Acquired by Amgen on Mar 4, 2021
Timeline
2000s
- Jun 1, 2002
Five Prime Therapeutics— Founded
2020s
- Mar 4, 2021
Amgen— Acquired By
Drugs by trial phase (10 distinct, 11 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT03801278Lead sponsorN/A—
- NCT04074759Lead sponsorPhase 1Nov 14, 2018
- NCT03694522Lead sponsorPhase 3Sep 14, 2018
- NCT03514121Lead sponsorEarly Phase 1Mar 27, 2018
- NCT03343301Study directorPhase 1Nov 30, 2017
- NCT03343301Lead sponsorPhase 1Nov 30, 2017
- NCT02526017Study directorPhase 1Sep 1, 2015
- NCT02526017Lead sponsorPhase 1Sep 1, 2015
- NCT02471716Lead sponsorPhase 1/Phase 2Jun 1, 2015
- NCT02471716Study directorPhase 1/Phase 2Jun 1, 2015
- NCT02318329Study directorPhase 1Nov 1, 2014
- NCT02318329Lead sponsorPhase 1Nov 1, 2014
- NCT01962337Lead sponsorPhase 1Oct 1, 2013
- NCT01962337Study directorPhase 1Oct 1, 2013
- NCT01244438Study chairPhase 2Jan 1, 2011
Details
- Founded
- San Francisco, CA, US Jun 1, 2002
- Last known activity
- Nov 14, 2018